Evidence supporting the use of: Piracetam
For the health condition: Concentration (poor)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Piracetam is a nootropic compound that has been studied for its effects on cognitive function, including concentration. Scientific interest in piracetam began in the late 1960s, with its developers proposing that it could enhance brain function in both healthy individuals and those with cognitive impairments. Several clinical trials and systematic reviews have evaluated piracetam’s effects on cognition. While some early studies in older adults and patients with cognitive decline (such as those with dementia or post-stroke cognitive impairment) suggested modest improvements in memory, attention, and concentration, the overall quality of evidence remains low to moderate due to methodological limitations, small sample sizes, and inconsistent results.

In healthy adults or young populations with poor concentration but without neurological disease, the evidence is much weaker. Few high-quality, placebo-controlled studies have demonstrated a clear benefit for concentration in this group. Additionally, most regulatory agencies (including the FDA and EMA) do not approve piracetam for cognitive enhancement due to insufficient robust data. However, piracetam continues to be prescribed in some countries for cognitive symptoms, partly based on its relatively safe profile and the absence of serious side effects in most studies.

In summary, there is limited scientific validation for piracetam's use in supporting or treating poor concentration, with the best evidence coming from studies in elderly or cognitively impaired patients and little support in healthy individuals. The overall evidence rating is low (2/5).

More about Piracetam
More about Concentration (poor)

Products containing Piracetam

We currently have no products on Vitabase that contain this ingredient.